Komori
Olympus (7733) · InitiativeAdvanced

Integrated Management of the Global Group and 5 Executive Officers

First written in FY2019. 4 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2025.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020 – FY20252019: 120192020: 120202021: 020212022: 120222023: 120232024: 020242025: 12025
Same theme, other companies
Function-Based Group Governance through a CxO SystemA theme 37 companies write about · 0 as a headwind · 38 as a tailwind

The whole theme swung hardest in 2026: 3 of 28 companies on the "Worse" side.

15 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 37 companies compared. The sentences above are computed from all 37.
Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「The executive officers comprise 12 members: the Chair, President and Chief Executive Officer (CEO), Chief Medical Officer (CMO), Executive Officer for Gastrointestinal Solutions, Chief Financial Officer (CFO), Chief Strategy Officer (CSO), Chief Manufacturing and Supply Officer (CMSO), Executive Officer for Surgical Interventions Solutions, Chief Technology Officer (CTO), Chief Human Resources Officer (CHRO), Chief Quality Officer (CQO), and Global General Counsel. They accelerate and improve the efficiency of decision-making across the Olympus Group and centrally manage risk throughout the Group.」

    The integrated global group management structure was reorganized into 12 executive officers, including the heads of the healthcare businesses, the CMO, the CQO, and the GGC.
  2. FY2023AdvancedAnnual report

    「The executive officers comprise 10 members: the Chair, President and Chief Executive Officer (CEO), Head of the Endoscopic Solutions Division, Head of the Therapeutic Solutions Division, Chief Financial Officer (CFO), Chief Strategy Officer (CSO), Chief Manufacturing and Supply Officer (CMSO), Chief Technology Officer (CTO), Chief Human Resources Officer (CHRO), and Chief Quality Officer (CQO). They accelerate and improve the efficiency of decision-making across the Olympus Group and centrally manage risk throughout the Group.」

    The structure was expanded from the previous 5- and 6-member structures to 10 executive officers covering the business divisions, strategy, manufacturing and supply, technology, human resources, and quality.
  3. FY2022AdvancedAnnual report

    「The executive officers comprise 6 members: the Chief Executive Officer (CEO), Chief Operating Officer (COO), Chief Technology Officer (CTO), Chief Manufacturing and Supply Officer (CMSO), Chief Financial Officer (CFO), and Chief Administrative Officer (CAO). They accelerate and improve the efficiency of decision-making across the Olympus Group and centrally manage risk throughout the Group.」

    The integrated global group management structure was expanded from the previous 5-member structure to 6 executive officers with the addition of the CMSO.
  4. FY2020AdvancedAnnual report

    「The executive officers comprise 5 members: the Chief Executive Officer (CEO), Chief Operating Officer (COO), Chief Technology Officer (CTO), Chief Financial Officer (CFO), and Chief Administrative Officer (CAO). They accelerate and improve the efficiency of decision-making across the Olympus Group and centrally manage risk throughout the Group.」

    The Company described the operation of integrated global group management by 5 executive officers, including faster and more efficient decision-making and centralized risk management.
  5. FY2019First statedAnnual report

    「① Transition to an integrated global group management structure ・Strengthened leadership through a global management structure and 5 executive officers ・Faster decision-making and centralized risk management」

    As measures under Transform Olympus, the Company outlined a global management structure led by 5 executive officers, faster decision-making, and centralized risk management.
Moved together

"Global Compliance Management System" moved the same way as this thread, in the same document, in 4 of its 5 moves.

444444★123456
  1. ★This thread
  2. 1Global Compliance Management System4×
  3. 2Establishment of a Company-Wide Quality Management System4×
  4. 3Further expansion of operations centered on the healthcare business4×
  5. 4Maintaining Competitiveness in Gastrointestinal Endoscopy and Growing the Treatment Device and Surgical Businesses4×
  6. 5Continued strengthening of core technologies centered on healthcare4×
  7. 6Annual dividend increased to ¥174×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Olympus yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Integrated Management of the Global Group and 5 Executive Officers | OLYMPUS CORPORATION (7733) | Komori